Are you over 18 years old?
This website requires you to be 18 years or older to enter our website and see the content.
Your access is restricted because of your age.
No products in the cart.
Free shipping on orders over $200.00
Congratulations! You've got free shipping.Australians are increasingly injecting an unapproved weight-loss drug, Retatrutide, sourced from unregulated online suppliers. These products are often labelled "for research use only" or "not for human consumption," raising significant safety concerns due to unknown purity, potency, and potential for dangerous side effects. Health authorities and experts are issuing urgent warnings about the risks associated with these "bootlegged" substances.
Retatrutide, hailed by some as a "king of peptides," has gained traction online, particularly on platforms like TikTok, where fitness influencers share how-to guides and dosage recommendations. Despite its experimental status, these influencers often promote suppliers, leading to a surge in Australians purchasing the drug for personal use. Pharmaceutical company Eli Lilly, the developer of Retatrutide, is currently conducting phase 3 clinical trials, but the drug remains unapproved globally.
Experts warn that injecting unapproved Retatrutide carries substantial risks. Dr. Ian Musgrave, a molecular pharmacologist, highlights that the long-term side effects are unknown, and counterfeit versions pose manifold problems. These substances may not be purified to pharmaceutical-grade levels and can come from illicit, unregulated foreign suppliers. Potential side effects, similar to other GLP-1 agonists, could include pancreatitis, bowel obstructions, and stomach emptying issues. Furthermore, improperly folded peptides can lead to dangerous immune responses, such as anaphylaxis.
The Therapeutic Goods Administration (TGA) in Australia has been actively requesting the removal of unlawful advertisements for unregistered therapeutic goods. However, the sheer volume of online content and the nature of these "research chemicals" make enforcement challenging. The US Food and Drug Administration (FDA) has also issued warnings about companies illegally selling Retatrutide directly to consumers under the guise of "research purposes."
Retatrutide is a synthetic peptide engineered as a "triple hormone receptor" agonist. It activates GLP-1, GIP, and glucagon receptors, which are involved in insulin secretion, glucose uptake, energy expenditure, appetite control, and gastric emptying. This multi-receptor action makes it potentially more potent for weight loss and diabetes management compared to existing drugs like Ozempic (GLP-1 only) and Mounjaro (GLP-1 and GIP). Clinical trial results have shown significant weight loss, with some participants losing over a quarter of their body weight in less than a year. However, rapid weight loss can also lead to complications such as kidney stones, weakened bones, and loss of muscle mass, necessitating careful monitoring.
While TikTok has banned searches for "Retatrutide," content continues to proliferate. The TGA has requested the removal of thousands of online advertisements, but specific actions regarding Retatrutide are not detailed. Experts emphasize that purchasing and injecting unapproved substances bypasses crucial safety checks and regulatory oversight. Consumers are urged to be wary of online claims and to consult healthcare professionals for legitimate and approved treatments.
Added to cart
Check out our shop to see what's available